Om

Theraclion SA is a French medical device company that develops and markets non-invasive echotherapy systems based on high-intensity focused ultrasound (HIFU). The company’s current product portfolio includes SONOVEIN, a robotic platform for treating varicose veins linked to chronic venous insufficiency, and ECHOPULSE, a system used for the treatment of thyroid nodules and breast fibroadenomas. Theraclion also offers disposable and monitoring components designed to support its ultrasound-guided procedures. Its technology is aimed at replacing traditional surgery with office-based treatments that do not require incisions or leave scars, making it relevant in outpatient care and minimally invasive medicine. Founded in 2004 and headquartered in Malakoff, France, Theraclion serves the healthcare sector through specialized therapeutic ultrasound equipment and associated services.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I EBM TECHNOLOGIES MED ENDAVU: Køb EBM Technologies ($8409) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i EBM Technologies, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.